Glenmark Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹3,770.59 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.33 per cent from ₹3,900.62 crore. This corresponds to a year-on-year *(YoY) growth of 15.80 per cent.
Operating Profit
Operating Profit stands at ₹389.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.22 per cent from ₹685.42 crore. This corresponds to a year-on-year *(YoY) growth of 106.80 per cent.
PBDT
PBDT stands at ₹535.67 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.19 per cent from ₹688.45 crore. This corresponds to a year-on-year *(YoY) growth of 302.22 per cent.
Profit Before Tax
Profit Before Tax stands at ₹387.76 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.39 per cent from ₹534.00 crore. This corresponds to a year-on-year *(YoY) growth of 4,765.24 per cent.
Net Profit
Net Profit stands at ₹301.31 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 25.28 per cent from ₹403.23 crore. This represents a 6,779.22 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Glenmark Pharmaceuticals Ltd News
Glenmark Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Glenmark Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Glenmark Pharmaceuticals Ltd Research Reports
Glenmark Pharmaceuticals Ltd Financial Reports
Glenmark Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Glenmark Pharma. | 2.93% | 3.57% | 6.75% | 5.82% | 13.41% | 20.14% |
| Laurus Labs | 2.79% | -1.56% | 9.58% | 38.24% | 45.62% | 91.31% |
| Alkem Lab | 0.80% | 1.62% | 6.91% | 4.06% | -3.53% | 19.57% |
| Biocon | 2.70% | -4.38% | -1.56% | 16.92% | 9.56% | 9.45% |
| Abbott India | 1.19% | 3.24% | 0.79% | 3.56% | -6.08% | -22.89% |
| Ipca Labs. | 1.61% | 0.24% | 9.24% | 22.60% | 16.81% | 23.75% |
| Anthem Bioscienc | 1.51% | -1.26% | -0.76% | 2.04% | 23.06% | 4.06% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Glenn Saldanha
ED / WTD / Promoter : Cheryl Pinto
ED / President / Global CFO : Anurag Mantri
Non Executive Director : B E Saldanha
Independent Non Exe. Director : Sona Saira Ramasastry
Independent Non Exe. Director : Dipankar Bhattacharjee
Independent Non Exe. Director : V R Iyer
Independent Non Exe. Director : Pradeep Kumar Sinha
Company Sec. & Compli. Officer : Harish Kuber